[Simple coagulation prophylaxis using low-molecular heparin enoxaparin in pediatric hemodialysis].
The use of low molecular weight heparins for the prevention of clotting in extracorporeal circulation during hemodialysis has been reported in adults. In seven children (aged 7 to 18 years) with end stage renal failure an initial bolus of the low molecular weight heparin enoxaparin (dosage: 24 to 36 mg/m2) provided simple and proper anticoagulation with no hemorrhage during at least four hours. The tolerance was excellent.
Bianchetti
M G
MG
Abteilung für Nephrologie, Medizinische Universitätskinderklinik, Bern.
Speck
S
S
Müller
R
R
Oetliker
O H
OH
D000293:Adolescent; D002648:Child; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000628:therapy*; D006435:Renal Dialysis
D006495:Heparin, Low-Molecular-Weight
Einfache Koagulationsprophylaxe mit dem niedermolekularen Heparin Enoxaparin in der pädiatrischen Hämodialyse.